My group uses human neuroimaging to study brain dysfunction in mental disorders - the causal pathway from genetic liability to pathophysiology to cognitive impairment and psychopathology in the development of schizophrenia, bipolar disorder and major depression. Using magnetoencephalography (MEG), electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) combined with biophysical modelling, we provide quantitative biomarkers for clinical research that allow for a biological nosology of mental disorders.
My primary area of responsibility is research in psychiatric neuroscience. Our main projects focus on neuroimaging in the Danish High-Risk and Resilience Study (VIA) and the Region Midt Schizophrenia (RMS) cohort using brain MEG and MRI. Currently, I am also working to implement brain imaging in individuals with Autism Spectrum Disorder and ADHD.
